Enhancement of farnesyl diphosphate pool as direct precursor of sesquiterpenes through metabolic engineering of the mevalonate pathway in Saccharomyces cerevisiae

The mevalonate pathway in the yeast Saccharomyces cerevisiae was deregulated in order to enhance the intracellular pool of farnesyl diphosphate (FPP), the direct precursor for the biosynthesis of sesquiterpenes. Over‐expression of the catalytic domain of HMG1, both from the genome and plasmid, resulted in higher production of cubebol, a plant originating sesquiterpene, and increased squalene accumulation. Down‐regulation of ERG9 by replacing its native promoter with the regulatable MET3 promoter, enhanced cubebol titers but simultaneous over‐expression of tHMG1 and repression of ERG9 did not further improve cubebol production. Furtheremore, the concentrations of squalene and ergosterol were measured in the engineered strains. Unexpectedly, significant accumulation of squalene and restoring the ergosterol biosynthesis were observed in the ERG9 repressed strains transformed with the plasmids harboring cubebol synthase gene. This could be explained by a toxicity effect of cubebol, possibly resulting in higher transcription levels for the genes under control of MET3 promoter, which could lead to accumulation of squalene and ergosterol. Biotechnol. Bioeng. 2010; 106: 86–96. © 2010 Wiley Periodicals, Inc.

[1]  J. Nielsen,et al.  Metabolic control analysis of biochemical pathways based on a thermokinetic description of reaction rates. , 1997, The Biochemical journal.

[2]  G. Robinson,et al.  Molecular cloning and characterization of the yeast gene for squalene synthetase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Eleonore Fröhlich,et al.  A Yeast Mutant Showing Diagnostic Markers of Early and Late Apoptosis , 1997, The Journal of cell biology.

[4]  Ulf Stahl,et al.  Combined overexpression of genes of the ergosterol biosynthetic pathway leads to accumulation of sterols in Saccharomyces cerevisiae. , 2003, FEMS yeast research.

[5]  B. Kemp,et al.  Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. , 1994, The Journal of biological chemistry.

[6]  Jing Wang,et al.  High-Level Production of Beta-Carotene in Saccharomyces cerevisiae by Successive Transformation with Carotenogenic Genes from Xanthophyllomyces dendrorhous , 2007, Applied and Environmental Microbiology.

[7]  J. D. Connolly,et al.  Dictionary of terpenoids , 1991 .

[8]  D. Kontoyiannis,et al.  Extra Copies of the Aspergillus fumigatus Squalene Epoxidase Gene Confer Resistance to Terbinafine: Genetic Approach to Studying Gene Dose-Dependent Resistance to Antifungals in A. fumigatus , 2004, Antimicrobial Agents and Chemotherapy.

[9]  R. Gardner,et al.  A Highly Conserved Signal Controls Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) Reductase in Eukaryotes* , 1999, The Journal of Biological Chemistry.

[10]  M. Bard,et al.  Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae. , 1999, Biochimica et biophysica acta.

[11]  S. Picaud,et al.  Expression, purification, and characterization of recombinant amorpha-4,11-diene synthase from Artemisia annua L. , 2005, Archives of biochemistry and biophysics.

[12]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[13]  J. Keasling,et al.  Engineering triterpene production in Saccharomyces cerevisiae–β‐amyrin synthase from Artemisia annua , 2008, The FEBS journal.

[14]  Jay D Keasling,et al.  Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids. , 2007, Metabolic engineering.

[15]  Robert J. D. Reid,et al.  Efficient PCR‐based gene disruption in Saccharomyces strains using intergenic primers , 2002, Yeast.

[16]  H. Iwahashi,et al.  Response of Saccharomyces cerevisiae to a monoterpene: evaluation of antifungal potential by DNA microarray analysis. , 2004, The Journal of antimicrobial chemotherapy.

[17]  R Rothstein,et al.  Cloning-free PCR-based allele replacement methods. , 1997, Genome research.

[18]  P. Lograsso,et al.  Overexpression, purification, and kinetic characterization of a carboxyl-terminal-truncated yeast squalene synthetase. , 1993, Archives of biochemistry and biophysics.

[19]  U. Stahl,et al.  Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast , 1998, Applied Microbiology and Biotechnology.

[20]  Jay D Keasling,et al.  Redirection of flux through the FPP branch‐point in Saccharomyces cerevisiae by down‐regulating squalene synthase , 2008, Biotechnology and bioengineering.

[21]  J. Nielsen,et al.  Carbon catabolite repression of invertase during batch cultivations of Saccharomyces cerevisiae: the role of glucose, fructose, and mannose , 1998, Applied Microbiology and Biotechnology.

[22]  M. Ghannoum,et al.  Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine , 2003, Antimicrobial Agents and Chemotherapy.

[23]  M. Basson,et al.  Identifying mutations in duplicated functions in Saccharomyces cerevisiae: recessive mutations in HMG-CoA reductase genes. , 1987, Genetics.

[24]  S. Matsuda,et al.  Metabolic engineering to produce sesquiterpenes in yeast. , 2003, Organic letters.

[25]  W. A. Scheffers,et al.  Effect of benzoic acid on metabolic fluxes in yeasts: A continuous‐culture study on the regulation of respiration and alcoholic fermentation , 1992, Yeast.

[26]  S. Picaud,et al.  Cloning, expression, purification and characterization of recombinant (+)-germacrene D synthase from Zingiber officinale. , 2006, Archives of biochemistry and biophysics.

[27]  J. Scott,et al.  Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. , 1994, The Journal of biological chemistry.

[28]  J. Rine,et al.  The biology of HMG-CoA reductase: the pros of contra-regulation. , 1996, Trends in biochemical sciences.

[29]  R. Hampton,et al.  Effects of overproduction of the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase on squalene synthesis in Saccharomyces cerevisiae , 1997, Applied and environmental microbiology.

[30]  K. Patil,et al.  Enhancing sesquiterpene production in Saccharomyces cerevisiae through in silico driven metabolic engineering. , 2009, Metabolic engineering.

[31]  Hisako Watanabe,et al.  Enzymatic properties of squalene epoxidase from Saccharomyces cerevisiae. , 1993, Biological & pharmaceutical bulletin.

[32]  P. S. Devi,et al.  Evaluation of in vitro antimicrobial activity of leaf and stem essential oils of Chloroxylon swietenia DC. , 2008 .

[33]  S. Jennewein,et al.  Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. , 2008, Metabolic engineering.

[34]  Jens Nielsen,et al.  Reconstruction of a bacterial isoprenoid biosynthetic pathway in Saccharomyces cerevisiae , 2008, FEBS letters.

[35]  Anthony Clark,et al.  Microbial isoprenoid production: an example of green chemistry through metabolic engineering. , 2005, Advances in biochemical engineering/biotechnology.

[36]  H. Kacser,et al.  Responses of metabolic systems to large changes in enzyme activities and effectors. 1. The linear treatment of unbranched chains. , 1993, European journal of biochemistry.

[37]  Jens Nielsen,et al.  Production of plant sesquiterpenes in Saccharomyces cerevisiae: Effect of ERG9 repression on sesquiterpene biosynthesis , 2008, Biotechnology and bioengineering.

[38]  Shunji Takahashi,et al.  Metabolic engineering of sesquiterpene metabolism in yeast , 2007, Biotechnology and bioengineering.

[39]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[40]  J. Piškur,et al.  Bacterial Toxin-Antitoxin Gene System as Containment Control in Yeast Cells , 2000, Applied and Environmental Microbiology.

[41]  H. Y. Steensma,et al.  The Two Acetyl-coenzyme A Synthetases of Saccharomyces cerevisiae Differ with Respect to Kinetic Properties and Transcriptional Regulation* , 1996, The Journal of Biological Chemistry.

[42]  Jenny Schelin,et al.  Production of the Artemisinin Precursor Amorpha-4,11-diene by Engineered Saccharomyces cerevisiae , 2006, Biotechnology Letters.

[43]  J. Haslam,et al.  The Effects of Catabolite Derepression on the Accumulation of Steryl Esters and the Activity of β-Hydroxymethylglutaryl-CoA Reductase in Saccharomyces cerevisiae , 1979 .

[44]  A. Pietsch,et al.  Concentration of squalene from shark liver oil by short-path distillation , 2007 .